Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC25A15 |
| Upstream (Parents) |
|---|
| (<<) PXMP2 → SLC25A15 |
| (<<) SORD → SLC25A15 |
| (<<) RAB17 → SLC25A15 |
| Downstream (Children) |
|---|
| SLC25A15 → HNF4A (>>) |
| SLC25A15 → CXCR1 (>>) |
| SLC25A15 → BHLHE41 (>>) |
| SLC25A15 → SIX2 (>>) |
| SLC25A15 → HCFC1R1 (>>) |
| SLC25A15 → KCNJ4 (>>) |
| SLC25A15 → FOS (>>) |
| SLC25A15 → KRT85 (>>) |
| SLC25A15 → GNAI2 (>>) |
| SLC25A15 → IL17RB (>>) |
| SLC25A15 → CHST11 (>>) |
| SLC25A15 → TGFB1I1 (>>) |
| SLC25A15 → PHGDH (>>) |
| SLC25A15 → SH3BGRL3 (>>) |
| SLC25A15 → PAIP2B (>>) |
